Page 248 - Read Online

Qu et al. Etiological prevention of liver cancer

lamivudine use in late pregnancy safely reduces perinatal transmission humoral and cellular immune response to hepatitis B vaccine in high-
of hepatitis B virus in real-life practice. Hepatology 2014;60:468-76. risk children 18-20 years after neonatal immunization. Viral Immunol
72. Han GR, Cao MK, Zhao W, Jiang HX, Wang CM, Bai SF, Yue X, 2009;22:125-30.
Wang GJ, Tang X, Fang ZX. A prospective and open-label study for 83. Zhu CL, Liu P, Chen T, Ni Z, Lu LL, Huang F, Lu J, Sun Z, Qu C.
the efficacy and safety of telbivudine in pregnancy for the prevention Presence of immune memory and immunity to hepatitis B virus in
of perinatal transmission of hepatitis B virus infection. J Hepatol adults after neonatal hepatitis B vaccination. Vaccine 2011;29:7835-41.
2011;55:1215-21. 84. But DY, Lai CL, Lim WL, Fung J, Wong DK, Yuen MF. Twenty-
73. Chen HL, Lee CN, Chang CH, Ni YH, Shyu MK, Chen SM, Hu JJ, two years follow-up of a prospective randomized trial of hepatitis
Lin HH, Zhao LL, Mu SC, Lai MW, Lee CL, Lin HM, Tsai MS, B vaccines without booster dose in children: final report. Vaccine
Hsu JJ, Chen DS, Chan KA, Chang MH; Taiwan Study Group for 2008;26:6587-91.
the Prevention of Mother-to-Infant Transmission of HBV (PreMIT 85. McMahon BJ, Dentinger CM, Bruden D, Zanis C, Peters H, Hurlburt
Study); Taiwan Study Group for the Prevention of Mother-to-Infant D, Bulkow L, Fiore AE, Bell BP, Hennessy TW. Antibody levels and
Transmission of HBV PreMIT Study. Efficacy of maternal tenofovir protection after hepatitis B vaccine: results of a 22-year follow-up
disoproxil fumarate in interrupting mother-to-infant transmission of study and response to a booster dose. J Infect Dis 2009;200:1390-6.
hepatitis B virus. Hepatology 2015;62:375-86. 86. Neaigus A, Gyarmathy VA, Zhao M, Miller M, Friedman SR, Des
74. Pan CQ, Duan Z, Dai E, Zhang S, Han G, Wang Y, Zhang H, Zou Jarlais DC. Sexual and other noninjection risks for HBV and HCV
H, Zhu B, Zhao W, Jiang H; China Study Group for the Mother-to- seroconversions among noninjecting heroin users. J Infect Dis
Child Transmission of Hepatitis B. Tenofovir to prevent hepatitis 2007;195:1052-61.
B transmission in mothers with high viral load. N Engl J Med 87. Xu L, Wei Y, Chen T, Lu J, Zhu CL, Ni Z, Huang F, Du J, Sun Z,
2016;374:2324-34. Qu C. Occult HBV infection in anti-HBs-positive young adults after
75. Wainwright RB, Bulkow LR, Parkinson AJ, Zanis C, McMahon neonatal HB vaccination. Vaccine 2010;28:5986-92.
BJ. Protection provided by hepatitis B vaccine in a Yupik Eskimo 88. Wu TW, Lin HH, Wang LY. Chronic hepatitis B infection in
population--results of a 10-year study. J Infect Dis 1997;175:674-7. adolescents who received primary infantile vaccination. Hepatology
76. Dentinger CM, McMahon BJ, Butler JC, Dunaway CE, Zanis CL, 2013;57:37-45.
Bulkow LR, Bruden DL, Nainan OV, Khristova ML, Hennessy TW, 89. Hong M, Sandalova E, Low D, Gehring AJ, Fieni S, Amadei B, Urbani
Parkinson AJ. Persistence of antibody to hepatitis B and protection S, Chong YS, Guccione E, Bertoletti A. Trained immunity in newborn
from disease among Alaska natives immunized at birth. Pediatr Infect infants of HBV-infected mothers. Nat Commun 2015;6:6588.
Dis J 2005;24:786-92. 90. Lee AK, Ip HM, Wong VC. Mechanisms of maternal-fetal
77. Beasley RP, Hwang LY, Lin CC, Ko YC, Twu SJ. Incidence of transmission of hepatitis B virus. J Infect Dis 1978;138:668-71.
hepatitis among students at a university in Taiwan. Am J Epidemiol 91. Starr TK, Jameson SC, Hogquist KA. Positive and negative selection
1983;117:213-22. of T cells. Annu Rev Immunol 2003;21:139-76.
78. Zanetti AR, Mariano A, Romanò L, D’Amelio R, Chironna M, 92. Crotty S. A brief history of T cell help to B cells. Nat Rev Immunol
Coppola RC, Cuccia M, Mangione R, Marrone F, Negrone FS, 2015;15:185-9.
Parlato A, Zamparo E, Zotti C, Stroffolini T, Mele A; Study Group. 93. Fazilleau N, McHeyzer-Williams LJ, Rosen H, McHeyzer-Williams
Long-term immunogenicity of hepatitis B vaccination and policy for MG. The function of follicular helper T cells is regulated by the
booster: an Italian multicentre study. Lancet 2005;366:1379-84. strength of T cell antigen receptor binding. Nat Immunol 2009;10:375-
79. FitzSimons D, Hendrickx G, Vorsters A, Van Damme P. Hepatitis B 84.
vaccination: a completed schedule enough to control HBV lifelong? 94. Nurieva RI, Chung Y, Martinez GJ, Yang XO, Tanaka S, Matskevitch
Milan, Italy, 17-18 November 2011. Vaccine 2013;31:584-90. TD, Wang YH, Dong C. Bcl6 mediates the development of T follicular
80. Lu CY, Ni YH, Chiang BL, Chen PJ, Chang MH, Chang LY, Su helper cells. Science 2009;325:1001-5.
IJ, Kuo HS, Huang LM, Chen DS, Lee CY. Humoral and cellular 95. Romanò L, Carsetti R, Tozzi AE, Mele A, Zanetti AR. Chronic
immune responses to a hepatitis B vaccine booster 15-18 years after hepatitis B infection in adolescents vaccinated at birth: an alarm bell
neonatal immunization. J Infect Dis 2008;197:1419-26. in favor of the need for a booster? Hepatology 2014;59:349.
81. Jan CF, Huang KC, Chien YC, Greydanus DE, Davies HD, Chiu TY, 96. Carmody E. Time to re-evaluate the effect of the adolescent booster of
Huang LM, Chen CJ, Chen DS. Determination of immune memory hepatitis B vaccine. Int J Infect Dis 2017;60:88-90.
to hepatitis B vaccination through early booster response in college 97. Liu J, Zhang S, Wang Q, Shen H, Zhang M, Zhang Y, Yan D, Liu M.
students. Hepatology 2010;51:1547-54. Seroepidemiology of hepatitis B virus infection in 2 million men aged
82. Chinchai T, Chirathaworn C, Praianantathavorn K, Theamboonlers A, 21-49 years in rural China: a population-based, cross-sectional study.
Hutagalung Y, Bock PH, Thantiworasit P, Poovorawan Y. Long-term Lancet Infect Dis 2016;16:80-6.

240 Hepatoma Research ¦ Volume 3 ¦ October 25, 2017